BankPlus Trust Department’s abrdn Life Sciences Investors HQL Stock Holding History

BankPlus Trust Department’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.7K	Hold	2,134	–	–	0.01%	285
2026 Q1	$34.7K	Hold	2,134	–	–	0.01%	294
2025 Q4	$35.8K	Hold	2,134	–	–	0.01%	280
2025 Q3	$33.1K	Hold	2,134	–	–	0.01%	280
2025 Q2	$27.3K	Hold	2,134	–	–	0.01%	283
2025 Q1	$27.1K	Hold	2,134	–	–	0.01%	281
2024 Q4	$28K	Buy	+2,134	New	+$30.8K	0.01%	273

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

BankPlus Trust Department's HQL Position: Q2 2026 in Review

BankPlus Trust Department held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 2,134 shares worth $42.7K. The position accounts for 0.01% of the portfolio, ranked #285.

BankPlus Trust Department first reported a position in HQL in Q4 2024 and has held it in 7 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

BankPlus Trust Department held 2,134 shares of abrdn Life Sciences Investors worth $42.7K as of Q2 2026.
BankPlus Trust Department left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
abrdn Life Sciences Investors made up 0.01% of BankPlus Trust Department's portfolio in Q2 2026, its #285 holding.
BankPlus Trust Department first reported a position in abrdn Life Sciences Investors in Q4 2024 and has held it in 7 quarters since.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.